| 摘要 |
2108754 9220706 PCTABS00017 Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in controlling hypertension, myocardial infarction, metabolic, endocrinological, and neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrythmias, asthma, acute renal failure, preeclampsia, and diabetes.
|
